Rhythm Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
CEODavid P. Meeker
CEODavid P. Meeker
Employees283
Employees283
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2008
Founded2008
Employees283
Employees283
RYTM Key Statistics
Market cap7.05B
Market cap7.05B
Price-Earnings ratio-34.06
Price-Earnings ratio-34.06
Dividend yield—
Dividend yield—
Average volume736.11K
Average volume736.11K
High today$107.50
High today$107.50
Low today$102.76
Low today$102.76
Open price$104.63
Open price$104.63
Volume546.02K
Volume546.02K
52 Week high$116.00
52 Week high$116.00
52 Week low$45.91
52 Week low$45.91
Stock Snapshot
The current Rhythm Pharmaceuticals(RYTM) stock price is $105.70, with a market capitalization of 7.05B. The stock trades at a price-to-earnings (P/E) ratio of -34.06.
During the trading session on 2025-12-04, Rhythm Pharmaceuticals(RYTM) shares reached a daily high of $107.50 and a low of $102.76. At a current price of $105.70, the stock is +2.9% higher than the low and still -1.7% under the high.
Trading volume for Rhythm Pharmaceuticals(RYTM) stock has reached 546.02K, versus its average volume of 736.11K.
The stock's 52-week range extends from a low of $45.91 to a high of $116.00.
The stock's 52-week range extends from a low of $45.91 to a high of $116.00.
Analyst ratings
93%
of 15 ratingsBuy
93.3%
Hold
6.7%
Sell
0%
People also own
Based on the portfolios of people who own RYTM. This list is generated using Robinhood data, and it’s not a recommendation.